| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | 2.44e-03 | 891 | 22 | 5 | GO:0008270 | |
| Domain | - | 2.46e-03 | 222 | 23 | 3 | 1.25.10.10 | |
| Domain | ARM-like | 4.27e-03 | 270 | 23 | 3 | IPR011989 | |
| Domain | Helicase_C | 7.61e-03 | 107 | 23 | 2 | PF00271 | |
| Domain | HELICc | 7.61e-03 | 107 | 23 | 2 | SM00490 | |
| Domain | Helicase_C | 7.74e-03 | 108 | 23 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 7.88e-03 | 109 | 23 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 7.88e-03 | 109 | 23 | 2 | PS51192 | |
| Domain | DEXDc | 7.88e-03 | 109 | 23 | 2 | SM00487 | |
| Domain | ARM-type_fold | 8.02e-03 | 339 | 23 | 3 | IPR016024 | |
| Domain | Helicase_ATP-bd | 8.02e-03 | 110 | 23 | 2 | IPR014001 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 26750805 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.73e-05 | 1489 | 24 | 7 | 28611215 | |
| Pubmed | Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. | 2.68e-04 | 35 | 24 | 2 | 16452166 | |
| Pubmed | 4.24e-04 | 44 | 24 | 2 | 35493520 | ||
| Pubmed | 4.46e-04 | 218 | 24 | 3 | 19460752 | ||
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 4.64e-04 | 221 | 24 | 3 | 31950832 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 6.41e-04 | 247 | 24 | 3 | 32989298 | |
| Cytoband | 4q24 | 1.45e-04 | 34 | 24 | 2 | 4q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q24 | 4.40e-04 | 59 | 24 | 2 | chr4q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 4.12e-03 | 183 | 24 | 2 | chr16q22 | |
| GeneFamily | Ankyrin repeat domain containing | 1.67e-02 | 242 | 15 | 2 | 403 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 140 | 24 | 3 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.03e-04 | 171 | 24 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-04 | 173 | 24 | 3 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.20e-04 | 180 | 24 | 3 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.20e-04 | 180 | 24 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 183 | 24 | 3 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 183 | 24 | 3 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 188 | 24 | 3 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.45e-04 | 192 | 24 | 3 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-04 | 193 | 24 | 3 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-04 | 194 | 24 | 3 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-04 | 195 | 24 | 3 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-04 | 195 | 24 | 3 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-04 | 195 | 24 | 3 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-04 | 195 | 24 | 3 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.63e-04 | 200 | 24 | 3 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 1.63e-04 | 200 | 24 | 3 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| Disease | carbohydrate intake measurement | 3.50e-04 | 34 | 24 | 2 | EFO_0010811 | |
| Disease | Antithrombotic agent use measurement | 9.17e-04 | 55 | 24 | 2 | EFO_0009925 | |
| Disease | Liver Dysfunction | 1.57e-03 | 72 | 24 | 2 | C0086565 | |
| Disease | Liver diseases | 1.57e-03 | 72 | 24 | 2 | C0023895 | |
| Disease | S-6-hydroxywarfarin measurement | 3.21e-03 | 368 | 24 | 3 | EFO_0803326 | |
| Disease | prostate cancer (is_implicated_in) | 4.06e-03 | 117 | 24 | 2 | DOID:10283 (is_implicated_in) | |
| Disease | tea consumption measurement | 4.91e-03 | 129 | 24 | 2 | EFO_0010091 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 5.68e-03 | 139 | 24 | 2 | DOID:3908 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 8.29e-03 | 169 | 24 | 2 | DOID:3908 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQQQMLKLMSVRLCP | 336 | P24298 | |
| QMQNRMVILLCNLKP | 201 | Q12904 | |
| LEQLNSLGCMTNMNL | 106 | Q5T5M9 | |
| QGMPKNCLLILILSM | 541 | Q8TD91 | |
| ELINMNLAQLCSLLM | 301 | Q9P2D6 | |
| MNCQQLWLGFLLPMT | 1 | Q99542 | |
| QLSLMDLMLVCNIVP | 66 | Q8NHB1 | |
| LNLGMCNIKDMPNLT | 201 | Q9HBW1 | |
| LQLNPCLAMLMALQS | 2781 | Q9Y4D8 | |
| MNLTSPLLQCNMSAT | 1821 | Q92794 | |
| ASGCLQNMLLKSLQM | 516 | Q9UFP1 | |
| IALEQLCMLLLMSDN | 26 | Q9ULT8 | |
| LCLMMQPSHLPIDLN | 611 | O14981 | |
| QRMLPRNCQMLLFSA | 261 | Q9UMR2 | |
| MLLMWDALNQPNLTC | 351 | Q9Y2A9 | |
| LYVNMLRNNPSCMLE | 411 | Q9Y4J8 | |
| MMDNLPDLITQCIQL | 201 | Q6ZR62 | |
| MLCILKLASQMPLEN | 2011 | Q86VV8 | |
| EPNCNLDLLMAMLFT | 151 | Q8NBS3 | |
| PNMCHLQLMETFLIL | 151 | Q5T9Z0 | |
| NNVMTLCAMLPLLLF | 81 | Q99808 | |
| LSKMPACNIMLLGAQ | 241 | Q8WWY3 | |
| MLRCPLCQDMLNNKI | 1251 | Q15911 | |
| HLAMMSNSLPCLLLL | 656 | P19838 |